FDA Drug Approval, N019670, CLARITIN-D
FDA Drug Approval, N019670, CLARITIN-D
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 019670
Company: BAYER HEALTHCARE LLC
Drug Name: CLARITIN-D
Active Ingredients: LORATADINE; PSEUDOEPHEDRINE SULFATE
Strength: 5MG;120MG
Dosage Form/Route: TABLET, EXTENDED RELEASE;ORAL
Action Date: 11/14/1994
Marketing Status: Over-the-counter
Submission Classification: Type 4 - New Combination
Company: BAYER HEALTHCARE LLC
Drug Name: CLARITIN-D
Active Ingredients: LORATADINE; PSEUDOEPHEDRINE SULFATE
Strength: 5MG;120MG
Dosage Form/Route: TABLET, EXTENDED RELEASE;ORAL
Action Date: 11/14/1994
Marketing Status: Over-the-counter
Submission Classification: Type 4 - New Combination
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details